Clinical and Psychological Predictors of Switching from Active Surveillance to Active Treatment among Men with Low-Risk Prostate Cancer: the PREPARE Prospective Cohort Study

被引：0
|
作者：
Taylor, K. L.
Luta, G.
Zotou, V
Hoffman, R. M.
Lobo, T.
Davis, K. M.
Potosky, A. L.
Aaronson, D.
Van den Eeden, S.
机构：
来源：
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 2018年 / 27卷 / 03期
关键词：
D O I：
10.1158/1055-9965.EPI-18-0064
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：357 / 358
页数：2
相关论文
共 50 条
  • [1] Psychological predictors of delayed active treatment following active surveillance for low-risk prostate cancer: The Patient REported outcomes for Prostate cARE prospective cohort study
    Taylor, Kathryn L.
    Luta, George
    Zotou, Vasiliki
    Lobo, Tania
    Hoffman, Richard M.
    Davis, Kimberly M.
    Potosky, Arnold L.
    Li, Tengfei
    Aaronson, David
    Van Den Eeden, Stephen K.
    BJUI COMPASS, 2022, 3 (03): : 226 - 237
  • [2] PREDICTORS OF TRANSITION TO WATCHFUL WAITING FROM ACTIVE SURVEILLANCE AMONG MEN WITH LOW-RISK PROSTATE CANCER (FIVO COHORT)
    Carmen Mir, Maria
    Ramirez-Backhaus, Miguel
    Luis Dominguez-Escrig, Jose
    Casanova, Juan
    Iborra, Immaculada
    Collado, Argimiro
    Gomez-Ferrer, Alvaro
    Manuel Mascaros, Juan
    Rubio-Briones, Jose
    JOURNAL OF UROLOGY, 2018, 199 (04): : E210 - E211
  • [3] Treatment Preferences for Active Surveillance versus Active Treatment among Men with Low-Risk Prostate Cancer
    Taylor, Kathryn L.
    Hoffman, Richard M.
    Davis, Kimberly M.
    Luta, George
    Leimpeter, Amethyst
    Lobo, Tania
    Kelly, Scott P.
    Shan, Jun
    Aaronson, David
    Tomko, Catherine A.
    Starosta, Amy J.
    Hagerman, Charlotte J.
    Van Den Eeden, Stephen K.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2016, 25 (08) : 1240 - 1250
  • [4] Utilization and Predictors of Active Surveillance among Elderly Men with Low-Risk Localized Prostate Cancer
    Tsai, Huei-Ting
    Potosky, Arnold
    Philips, George
    Taylor, Katherine
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 174 - 174
  • [5] Re: Treatment Preferences for Active Surveillance versus Active Treatment among Men with Low-Risk Prostate Cancer
    Penson, David F.
    JOURNAL OF UROLOGY, 2017, 197 (01): : 153 - 153
  • [6] Active surveillance for men with low-risk prostate cancer
    Sturch, Paul
    Kirby, Roger
    Challacombe, Ben
    TRENDS IN UROLOGY & MENS HEALTH, 2014, 5 (02) : 14 - 16
  • [7] Active Surveillance for Black Men With Low-Risk Prostate Cancer
    Shen, Xinglei
    Pettaway, Curtis A.
    Chen, Ronald C.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (17): : 1733 - 1734
  • [8] THE QUALITY OF ACTIVE SURVEILLANCE FOR MEN WITH LOW-RISK PROSTATE CANCER
    Levy, Mya E.
    Meyers, Stephanie
    Wood, David P.
    Montie, James E.
    Miller, David C.
    Wei, John T.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 179 - 179
  • [9] Intensity of Active Surveillance and Transition to Treatment in Men with Low-risk Prostate Cancer
    Olsson, Henrik
    Nordstrom, Tobias
    Clements, Mark
    Gronberg, Henrik
    Lantz, Anna Wallerstedt
    Eklund, Martin
    EUROPEAN UROLOGY ONCOLOGY, 2020, 3 (05): : 640 - 647
  • [10] Surveillance biopsy and active treatment during active surveillance for low-risk prostate cancer
    Katsuyoshi Hashine
    Hiroyuki Iio
    Yoshiteru Ueno
    Shohei Tsukimori
    Iku Ninomiya
    International Journal of Clinical Oncology, 2014, 19 : 531 - 535
12345